Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:15 PM
Ignite Modification Date:
2025-12-24 @ 9:15 PM
NCT ID:
NCT01371604
Eligibility Criteria:
Inclusion Criteria:
* Males and females with documented genotype 1, chronic hepatitis C infection.
* Must agree to use double-barrier method of birth control for at least 6 months after the last dose of study drugs.
* Has not received prior antiviral treatment for HCV.
* Written informed consent by participant.
Exclusion Criteria:
* Pregnant or breastfeeding.
* Co-infected with hepatitis B virus (HBV; hepatitis B surface antigen \[HBsAg\] positive) and/or human immunodeficiency virus (HIV).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT01371604
Study Brief:
Protocol Section:
NCT01371604